Boston Scientific Loses Patent Infringement Suit with Johnson & Johnson

April 20, 2009 - A federal judge has ruled that Boston Scientific must pay a 5.1 percent royalty rate on its sales of catheters that infringe the patents of Cordis Corp., a division of Johnson & Johnson. The rate set by US District Judge Susan Illston in San Francisco is much higher than the 0.5 percent that Boston Scientific had negotiated for.